Evidence map›Paper›PMID 40887598›Full record

ArticleDiagnostic and prognostic research2025

Development and internal validation of a prediction model for post-COVID-19 condition 2 years after infection-results of the CORFU study.

Dorthe Odyl Klein, Nick Wilmes, Sophie F Waardenburg, Gouke J Bonsel, Erwin Birnie, Marieke Sjn Wintjens, Stella Cm Heemskerk, Emma Bnj Janssen, Chahinda Ghossein-Doha, Michiel C Warlé and 12 more

Abstract read
In one paragraph

Article in Diagnostic and prognostic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Dorthe Odyl KleinDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center+ (MUMC+), P.O. Box 5800, 6202, AZ, Maastricht, The Netherlands. dorthe.klein@mumc.nl.
Nick WilmesCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Sophie F WaardenburgDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center+ (MUMC+), P.O. Box 5800, 6202, AZ, Maastricht, The Netherlands.
Gouke J BonselEuroQol Group Executive Office, Rotterdam, The Netherlands.
Erwin BirnieEuroQol Group Executive Office, Rotterdam, The Netherlands.
Marieke Sjn WintjensDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center+ (MUMC+), P.O. Box 5800, 6202, AZ, Maastricht, The Netherlands.
Stella Cm HeemskerkDepartment of Public Health, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Emma Bnj JanssenDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center+ (MUMC+), P.O. Box 5800, 6202, AZ, Maastricht, The Netherlands.
Chahinda Ghossein-DohaCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Michiel C WarléDepartment of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Lotte Mc JacobsDepartment of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Bea HemmenDepartment of Rehabilitation Medicine, Functioning, Participation & Rehabilitation, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Jeanine A VerbuntDepartment of Rehabilitation Medicine, Functioning, Participation & Rehabilitation, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Bas Ct van BusselDepartment of Intensive Care Medicine, Maastricht University Medical Center+, and Cardiovascular Research Institute Maastricht (CARIM) and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Susanne van SantenDepartment of Intensive Care Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.
Bas Ljh KietselaerDepartment of Cardiovascular Disease, Mayo Clinic, Mayo Clinic, MN, USA.
Gwyneth JansenDepartment of Cardiology, Zuyderland Medical Center, Heerlen, The Netherlands.
Folkert W AsselbergsDepartment of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Marijke LinschotenDepartment of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Juanita A HaagsmaDepartment of Public Health, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
S M J van KuijkDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center+ (MUMC+), P.O. Box 5800, 6202, AZ, Maastricht, The Netherlands.
CAPACITY-COVID Collaborative Consortium

Funding

Dutch Heart Foundation 2020B006 CAPACITYThe Netherlands Organization for Health Research and Development (ZonMW) 10430102110006 DEFENCE
6 · The paper itself

Abstract

backgroundA subset of COVID-19 patients develops post-COVID-19 condition (PCC). This condition results in disability in numerous areas of patients' lives and a reduced health-related quality of life, with societal impact including work absences and increased healthcare utilization. There is a scarcity of models predicting PCC, especially those considering the severity of the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and incorporating long-term follow-up data. Therefore, we developed and internally validated a prediction model for PCC 2 years after SARS-CoV-2 infection in a cohort of COVID-19 patients.

methodsData from the CORona Follow-Up (CORFU) study were used. This research initiative integrated data from multiple Dutch COVID-19 cohort studies. We utilized 2-year follow-up data collected via the questionnaires between October 1st of 2021 and December 31st of 2022. Participants were former COVID-19 patients, approximately 2-year post-SARS-CoV-2 infection. Candidate predictors were selected based on literature and availability across cohorts. The outcome of interest was the prevalence of PCC at 2 years after the initial infection. Logistic regression with backward stepwise elimination identified significant predictors such as sex, BMI and initial disease severity. The model was internally validated using bootstrapping. Model performance was quantified as model fit, discrimination and calibration.

resultsIn total 904 former COVID-19 patients were included in the analysis. The cohort included 146 (16.2%) non-hospitalized patients, 511 (56.5%) ward admitted patients, and 247 (27.3%) intensive care unit (ICU) admitted patients. Of all participants, 551 (61.0%) participants suffered from PCC. We included 20 candidate predictors in the multivariable analysis. The final model, after backward elimination, identified sex, body mass index (BMI), ward admission, ICU admission, and comorbidities such as arrhythmia, asthma, angina pectoris, previous stroke, hernia, osteoarthritis, and rheumatoid arthritis as predictors of post-COVID-19 condition. Nagelkerke's R-squared value for the model was 0.19. The optimism-adjusted AUC was 71.2%, and calibration was good across predicted probabilities.

conclusionsThis internally validated prediction model demonstrated moderate discriminative ability to predict PCC 2 years after COVID-19 based on sex, BMI, initial disease severity, and a collection of comorbidities.

Indexed as

Clinical prediction modelLong COVIDPost-acute sequelae of COVID-19Post-COVID-19 conditionPrognostic factors

Identifiers

PMID40887598
PMCPMC12400538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.